Literature DB >> 22481034

Can tissue-based immune markers be used for studying the natural history of cancer?

Jill Koshiol1, Shih-Wen Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22481034      PMCID： PMC3596808          DOI： 10.1016/j.annepidem.2012.03.001

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN： 1047-2797            Impact factor:   3.797


× No keyword cloud information.
  87 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 3.  A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Authors:  Robert L Camp; Veronique Neumeister; David L Rimm
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Authors:  Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; William Pao; Dennis C Sgroi; Marian L Birkeland
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

Review 6.  Myeloid-derived suppressor cells in human cancer.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

7.  Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population.

Authors:  G-Q Wang; C C Abnet; Q Shen; K J Lewin; X-D Sun; M J Roth; Y-L Qiao; S D Mark; Z-W Dong; P R Taylor; S M Dawsey
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

9.  Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China.

Authors:  Ann W Hsing; Lori C Sakoda; Asif Rashid; Gabriella Andreotti; Jinbo Chen; Bin-Shen Wang; Ming-Chang Shen; Bingshu E Chen; Philip S Rosenberg; Mingdong Zhang; Shelley Niwa; Lisa Chu; Robert Welch; Meredith Yeager; Joseph F Fraumeni; Yu-Tang Gao; Stephen J Chanock
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 10.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867
View more
  11 in total

1.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

2.  Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

Authors:  Yin Cao; Reiko Nishihara; Zhi Rong Qian; Mingyang Song; Kosuke Mima; Kentaro Inamura; Jonathan A Nowak; David A Drew; Paul Lochhead; Katsuhiko Nosho; Teppei Morikawa; Xuehong Zhang; Kana Wu; Molin Wang; Wendy S Garrett; Edward L Giovannucci; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal:  Gastroenterology       Date:  2016-07-27       Impact factor: 22.682

Review 3.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 4.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

5.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.

Authors:  Mingyang Song; Reiko Nishihara; Molin Wang; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Kana Wu; Shuji Ogino; Zhi Rong Qian; Kentaro Inamura; Xuehong Zhang; Kimmie Ng; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Katsuhiko Nosho
Journal:  Gut       Date:  2015-01-15       Impact factor: 23.059

6.  Proceedings of the second international molecular pathological epidemiology (MPE) meeting.

Authors:  Shuji Ogino; Peter T Campbell; Reiko Nishihara; Amanda I Phipps; Andrew H Beck; Mark E Sherman; Andrew T Chan; Melissa A Troester; Adam J Bass; Kathryn C Fitzgerald; Rafael A Irizarry; Karl T Kelsey; Hongmei Nan; Ulrike Peters; Elizabeth M Poole; Zhi Rong Qian; Rulla M Tamimi; Eric J Tchetgen Tchetgen; Shelley S Tworoger; Xuehong Zhang; Edward L Giovannucci; Piet A van den Brandt; Bernard A Rosner; Molin Wang; Nilanjan Chatterjee; Colin B Begg
Journal:  Cancer Causes Control       Date:  2015-05-09       Impact factor: 2.506

Review 7.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

Review 8.  Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors:  Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2015-12-04       Impact factor: 5.225

Review 9.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Authors:  Shuji Ogino; Paul Lochhead; Andrew T Chan; Reiko Nishihara; Eunyoung Cho; Brian M Wolpin; Jeffrey A Meyerhardt; Alexander Meissner; Eva S Schernhammer; Charles S Fuchs; Edward Giovannucci
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

Review 10.  Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer.

Authors:  Maret L Maliniak; Jasmine Miller-Kleinhenz; Deirdre P Cronin-Fenton; Timothy L Lash; Keerthi Gogineni; Emiel A M Janssen; Lauren E McCullough
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.